FDA authorizes first antiviral to treat COVID-19

Published



The Food and Drug Administration authorized an antiviral drug that has shown to be highly effective at preventing hospitalizations due to COVID-19, making it a powerful tool that could bolster the shaky medical system facing an omicron wave.

“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,” said Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.